Compounds > 1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea

1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea and Malaria

1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea has been researched along with Malaria* in 1 studies

Other Studies

1 other study(ies) available for 1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea and Malaria

Article	Year
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials. Science (New York, N.Y.), 2018, 12-07, Volume: 362, Issue:6419 To discover leads for next-generation chemoprotective antimalarial drugs, we tested more than 500,000 compounds for their ability to inhibit liver-stage development of luciferase-expressing Topics: Antimalarials; Chemoprevention; Drug Discovery; Drug Evaluation, Preclinical; Humans; Malaria; Mitochondria; Plasmodium	2018

Article

Year

Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.

Science (New York, N.Y.), 2018, 12-07, Volume: 362, Issue:6419

To discover leads for next-generation chemoprotective antimalarial drugs, we tested more than 500,000 compounds for their ability to inhibit liver-stage development of luciferase-expressing

Topics: Antimalarials; Chemoprevention; Drug Discovery; Drug Evaluation, Preclinical; Humans; Malaria; Mitochondria; Plasmodium

2018